Patient-reported outcome measures after COVID-19: a prospective cohort study

Abstract

Over 75% of patients admitted to hospital with COVID-19 have abnormal patient-reported outcome measures 3 months after symptom onset, with a third of patients reporting at least moderate impairment in major dimensions of quality of life https://bit.ly/32QMMgw

FIGURE 1

a) Patient reported outcomes 3 months after coronavirus disease 2019 (COVID-19) symptom onset stratified by the presence (red) or absence (blue) of Charlson comorbidities. Each circle represents a patient and the box represents the median and interquartile range. The y-axis shows the complete range of possible scores, and areas shaded in grey represent the normal range based on population adjusted norms where available. The provided normal threshold for dyspnoea is based on double the value of the minimum clinically important difference given the absence of an established normal range. b) Percentage of patients with impairment in each dimension of the 5-level EuroQoL 5-Dimensions (EQ-5D-5L). Results are shown for the total cohort (grey), and stratified by the presence (red) or absence (blue) of pre-existing Charlson comorbidities. Each dimension has five levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Patients who reported moderate problems or worse for a given dimension were considered to have impairment. PHQ: Patient Health Questionnaire; PSQI: Pittsburgh Sleep Quality Index; UCSD: University of California San Diego Shortness of Breath Questionnaire; VAS: Visual Analog Scale.